Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

In DMD, Summit Falls Well Short Of Peak It Hoped For

Jun 27 2018

• By Joseph Haas

Render illustration of Clinical Trial title on medical documents

Related Content

Sarepta’s $852m Summit Collaboration Could Enable DMD Drug Combinations

Oct 05 2016

Summit DMD Data Intrigue But Longer-Term Results Awaited

Jan 26 2018

Sarepta Outlines A Fast Path Forward For Its DMD Gene Therapy

Jun 19 2018

Related Companies

Summit Therapeutics Inc.

Sarepta Therapeutics, Inc.

Additional Topics

Rare Diseases Research & Development Clinical Trials Business Strategies BioPharmaceutical

More from Rare Diseases

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window